• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

LILM Stock News: Robbins LLP Investigates Lilium N.V. (LILM) f/k/a Qell Acquisition Corp. (QELL) on Behalf of Shareholders

By: Robbins LLP via Business Wire
May 03, 2022 at 17:49 PM EDT

Shareholder rights law firm Robbins LLP is investigating Lilium N.V. (NASDAQ: LILM, LILMW, QELL, QELLW) and its officers and directors to determine whether they breached their fiduciary duties and violated securities laws regarding the Company's ability to launch the Lilium Jet. Lilium purports to be a next-generation transportation company focused on developing an electric vertical take-off-and-landing ("eVTOL") aircraft for use in a new type of high-speed air transportation for people and goods.

If you would like more information about our investigation into Lilium N.V.'s misconduct, click here.

What is this Case About: According to a complaint filed against Lilium, the documents filed in support of the business combination between it and Qell Acquisition Corp. touted the Company's technology, team, and resources, and explained that the money raised from the business combination would "be used to fund the commercial launch of Lilium's 7-Seater Jet." However, defendants failed to disclose that Lilium had overstated the Lilium Jet's design and capabilities and its timely certification. Further, Lilium misrepresented its ability to obtain or create the necessary batteries for the Lilium Jet and failed to disclose the merger would not generate enough cash to commercially launch the Lilium Jet.

On March 14, 2022, market analyst Iceberg Research released a report entitled "LILIUM NV – THE LOSING HORSE IN THE EVTOL RACE," which detailed the current state of Lilium. Specifically, the report contends that Lilium is not on track to meet its certification timeline, the energy density of battery cells required by Lilium are currently not available commercially, and the Company only has 18 more months of cash on hand. On this news, Lilium's stock price fell 34% per share, to close at $2.44 per share on March 14, 2022.

Next Steps: If you acquired shares of Lilium N.V. (LILM) between March 30, 2021 and March 14, 2022, you have legal options. Contact us for more information.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas

(800) 350-6003

adumas@robbinsllp.com

Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Lilium N.V. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220503006354/en/

Contacts

Aaron Dumas

Robbins LLP

5040 Shoreham Place

San Diego, CA 92122

adumas@robbinsllp.com

(800) 350-6003

www.robbinsllp.com

More News

View More
Palantir’s New Healthcare Deal Boosts AI and Data Reach
October 15, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers ONMD PLTR
GM's Billion-Dollar Bruise: GM's Strategic Pivot Makes It a Buy
October 15, 2025
Via MarketBeat
Topics Electric Vehicles
Tickers GM
Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
October 15, 2025
Via MarketBeat
Topics World Trade
Tickers LLY NVO SEPN
ASML Can Hit New Highs, But It Won’t Be Easy: Here’s Why
October 15, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers ASML
Vertiv Stock Surges on Strategic CFO Hire and AI Momentum
October 15, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers NVDA VRT WAB
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap